BofA Gives Wave Life Sciences a Buy Rating, Eyes $38 Target

Bank of America starts coverage of Wave Life Sciences (WVE) with a Buy rating. Analyst highlights WVE-007 in obesity as a major growth driver, with peak sales above $11B.